![]() | This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||
|
The result of the move request was: page moved. Vegaswikian ( talk) 02:37, 30 April 2010 (UTC)
Danqi Jiaonang →
Neuroaid — Relisting.
Vegaswikian (
talk) 22:05, 20 April 2010 (UTC)
Danqi Jiaonang is a traditional chinese medecine which is currently used in China. Neuroaid is a stroke treatment which takes its origines in Danqi Jiaonang but which is more than simply Danqi Jiaonang.Furthermore All clinical trials stated in the page were made on neuroaid and not on Danqi Jiaonang. Argenlieu ( talk) 04:27, 12 April 2010 (UTC)
FYI, I have posted a query about this article on the WP:MED Talk page. Alexbrn talk| contribs| COI 07:37, 14 May 2013 (UTC)
From doi:10.1016/j.drudis.2012.02.011: NeuroAiD™ (MLC601 and MLC901), a traditional Chinese medicine has been used in China in patients after stroke as drugs to facilitate recovery after stroke since 2001. These agents combine nine herbal and five animal components. In vitro and in vivo results showed that NeuroAiD made cells more resistant against glutamate aggression, increased neurite outgrowth and connectivity and reduced infarct volume [41]. In a rodent model with focal ischemia an improved survival, brain protection and decreased functional deficits were demonstrated. MLC901 also prevented neuronal death in an in vitro model and induced neurogenesis in rodent and human cells [41]. Chen et al. analyzed the improvement of neurological recovery after stroke 2009 in clinical trials [42]. A recent study showed that MLC901 can also improve functional recovery of rats after global ischemia, because it was found to have an important role in neuroprotection [3]. Overall, NeuroAID, as it has already been effective in a cohort of Chinese patients with stroke, seems to represent an interesting agent in stroke treatment.
Refs:
I reverted a recent edit, which appeared promotional, as mentioned here. Biosthmors ( talk) 08:04, 15 August 2013 (UTC)
I've removed this sentence:
It has also shown effectiveness as a complementary treatment for other brain injuries and Alzheimer's disease. [1]
I have removed this sentence because the source is about a clinical trial that they plan to do sometime in the future. It is not a clinical trial that already happened. There is no data here and no conclusion that it is actually effective. (Also, that'd be a Adjuvant therapy, not necessarily a Complementary therapy.) WhatamIdoing ( talk) 17:16, 9 April 2022 (UTC)
I modified the short description ( diff) so that it now reads: "Supposed post-stroke ameliorative supplement". By "supposed" (pronunciation: \ sə-ˈpō-zəd \), I mean "erroneously imputed or ascribed". [1]. If that meaning does not seem clear, please edit for clarity. (It's clear to me, but not everyone is a word geek . ;^) Mark D Worthen PsyD (talk) [he/him] 17:33, 10 April 2022 (UTC)
References
![]() | This article is rated Start-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||
|
The result of the move request was: page moved. Vegaswikian ( talk) 02:37, 30 April 2010 (UTC)
Danqi Jiaonang →
Neuroaid — Relisting.
Vegaswikian (
talk) 22:05, 20 April 2010 (UTC)
Danqi Jiaonang is a traditional chinese medecine which is currently used in China. Neuroaid is a stroke treatment which takes its origines in Danqi Jiaonang but which is more than simply Danqi Jiaonang.Furthermore All clinical trials stated in the page were made on neuroaid and not on Danqi Jiaonang. Argenlieu ( talk) 04:27, 12 April 2010 (UTC)
FYI, I have posted a query about this article on the WP:MED Talk page. Alexbrn talk| contribs| COI 07:37, 14 May 2013 (UTC)
From doi:10.1016/j.drudis.2012.02.011: NeuroAiD™ (MLC601 and MLC901), a traditional Chinese medicine has been used in China in patients after stroke as drugs to facilitate recovery after stroke since 2001. These agents combine nine herbal and five animal components. In vitro and in vivo results showed that NeuroAiD made cells more resistant against glutamate aggression, increased neurite outgrowth and connectivity and reduced infarct volume [41]. In a rodent model with focal ischemia an improved survival, brain protection and decreased functional deficits were demonstrated. MLC901 also prevented neuronal death in an in vitro model and induced neurogenesis in rodent and human cells [41]. Chen et al. analyzed the improvement of neurological recovery after stroke 2009 in clinical trials [42]. A recent study showed that MLC901 can also improve functional recovery of rats after global ischemia, because it was found to have an important role in neuroprotection [3]. Overall, NeuroAID, as it has already been effective in a cohort of Chinese patients with stroke, seems to represent an interesting agent in stroke treatment.
Refs:
I reverted a recent edit, which appeared promotional, as mentioned here. Biosthmors ( talk) 08:04, 15 August 2013 (UTC)
I've removed this sentence:
It has also shown effectiveness as a complementary treatment for other brain injuries and Alzheimer's disease. [1]
I have removed this sentence because the source is about a clinical trial that they plan to do sometime in the future. It is not a clinical trial that already happened. There is no data here and no conclusion that it is actually effective. (Also, that'd be a Adjuvant therapy, not necessarily a Complementary therapy.) WhatamIdoing ( talk) 17:16, 9 April 2022 (UTC)
I modified the short description ( diff) so that it now reads: "Supposed post-stroke ameliorative supplement". By "supposed" (pronunciation: \ sə-ˈpō-zəd \), I mean "erroneously imputed or ascribed". [1]. If that meaning does not seem clear, please edit for clarity. (It's clear to me, but not everyone is a word geek . ;^) Mark D Worthen PsyD (talk) [he/him] 17:33, 10 April 2022 (UTC)
References